CSPC Innovation Pharmaceutical Co., Ltd. (SHE: 300765)

CSPC Innovation Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 12, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	35,929	42,873	9,767	8,376	7,858	7,140
Market Cap Growth	89.02%	338.97%	16.61%	6.58%	10.06%	-
Enterprise Value	35,571	39,717	7,864	6,725	6,463	5,759
Last Close Price	25.80	30.26	7.20	6.92	6.46	5.85
PE Ratio	70.01	55.59	13.25	23.53	25.36	23.66
PS Ratio	17.58	17.14	3.72	4.53	5.96	5.68
PB Ratio	9.42	8.43	2.48	2.54	2.92	2.96
P/TBV Ratio	12.03	8.52	2.51	2.59	3.00	3.04
P/FCF Ratio	-	51.56	18.54	86.64	33.97	34.12
P/OCF Ratio	-	46.24	15.24	28.68	22.51	22.64
EV/Sales Ratio	17.41	15.88	2.99	3.64	4.91	4.58
EV/EBITDA Ratio	54.64	45.47	9.60	13.34	16.26	17.30
EV/EBIT Ratio	67.03	51.30	10.53	15.46	18.78	20.16
EV/FCF Ratio	-416.98	47.76	14.93	69.57	27.94	27.52
Debt / Equity Ratio	0.00	0.00	0.01	0.00	-	-
Debt / EBITDA Ratio	0.00	0.00	0.02	0.00	-	-
Debt / FCF Ratio	-	0.00	0.04	0.01	-	-
Asset Turnover	0.37	0.49	0.63	0.55	0.45	0.59
Inventory Turnover	4.18	5.93	5.97	5.59	4.97	4.84
Quick Ratio	2.14	7.77	5.00	5.31	7.54	4.46
Current Ratio	2.69	8.26	5.47	6.09	8.17	4.83
Return on Equity (ROE)	10.78%	16.73%	20.07%	13.12%	11.75%	16.02%
Return on Assets (ROA)	6.03%	9.47%	11.22%	8.12%	7.41%	8.42%
Return on Capital (ROIC)	6.92%	10.69%	12.86%	9.08%	8.43%	10.25%
Earnings Yield	1.43%	1.76%	7.44%	4.69%	3.82%	3.83%
FCF Yield	-0.24%	1.94%	5.39%	1.15%	2.94%	2.93%
Dividend Yield	1.01%	0.88%	0.96%	1.00%	0.55%	0.41%
Payout Ratio	72.89%	12.95%	11.30%	10.68%	9.34%	-
Buyback Yield / Dilution	7.05%	-3.82%	0.02%	-13.53%	-6.56%	-24.77%
Total Shareholder Return	8.06%	-2.94%	0.98%	-12.53%	-6.01%	-24.36%

Source: S&P Capital IQ. Standard template. Financial Sources.